|
Oct 19
|
Is Coya Therapeutics (NASDAQ:COYA) In A Good Position To Invest In Growth?
|
|
Aug 8
|
Coya Therapeutics, Inc. Provides Business Update and Reports Q2 2023 Unaudited Financial Results
|
|
May 22
|
Coya to Present Additional Biomarker and Brain Imaging Data for COYA 301 in Alzheimer’s Disease (AD) at the LD Micro Conference on June 7, 2023
|
|
May 16
|
Why Coya Therapeutics Shares Are Shooting Higher Today
|
|
May 16
|
Here's Why Momentum in Coya Therapeutics, Inc. (COYA) Should Keep going
|
|
May 16
|
Coya Therapeutics’ COYA 301 Increased Treg Function and Halted Cognitive Decline in an Open Label Study in Patients with Alzheimer’s Disease
|